Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models
Authors:
- Stefania PizzimentiSPStefania Pizzimenti
- Martina DagaMDMartina Daga
- Eric CiamporceroECEric Ciamporcero
- Cristina ToaldoCTCristina Toaldo
- Piergiorgio PettazzoniPPPiergiorgio Pettazzoni
- Simona Osella-AbateSOSimona Osella-Abate
- Mauro NovelliMNMauro Novelli
- Rosalba MinelliRMRosalba Minelli
- Agnese BisazzaABAgnese Bisazza
- Paola GambaPaola Gamba
- Gabriella TestaGTGabriella Testa
- Chiara UllioCUChiara Ullio
- 1 December 2015
- journal article
- research article
- Published by American Scientific Publishers in Journal of Biomedical Nanotechnology
- Vol. 11 (12) , 2169-2185
Abstract
4-hydroxynonenal (HNE), a lipid peroxidation product, is a promising anti-neoplastic drug due to its remarkable anti-cancer activities. However, this possibility has not been explored, because the delivery of HNE is very challenging as a result of its low solubility and its poor stability. This study intentionally designed a new type of lipid nanocapsules specifically for HNE delivery. They consist of a medium chain triglyceride liquid oil core surrounded by a polymer shell. A β-cyclodextrin-poly(4-acryloylmorpholine) conjugate was selected as the shell component. HNE-loaded nanocapsules were about 350 nm in size with a negative surface charge. They were stable for two years when stored in suspensions at 4 °C. In vitro experiments showed that HNE was released from the nanocapsules at a considerable rate. Nanocapsule uptake into cells was evaluated using a fluorescent formulation that revealed rapid internalisation. Cytotoxicity studies demonstrated the safety of the formulation. Enhanced anti-tumoral activity against various cell lines, depending on increased HNE stability, was obtained by using HNE-loaded nanocapsules. In particular, we have demonstrated an increase in anti-proliferative, pro-apoptotic and differentiative activity in several tumour cell lines from different tissues. Moreover, we evaluated the effects of these new nanocapsules on a three-dimensional human reconstructed model of skin melanoma. Interestingly, the encouraging results obtained with topical administration on the epidermal surface could open new perspectives in melanoma treatments.Keywords
This publication has 39 references indexed in Scilit:
- Nanoparticles in drug delivery: Past, present and futureAdvanced Drug Delivery Reviews, 2013
- Lipid nanocapsules for dermal application: A comparative study of lipid-based versus polymer-based nanocarriersEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Formulation of lipid core nanocapsulesColloids and Surfaces A: Physicochemical and Engineering Aspects, 2011
- Optimization of the Tetrazolium Dye (MTT) Colorimetric Assay for Cellular Growth and Viability2011
- Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicityEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenalArchives of Biochemistry and Biophysics, 2008
- Use of cyclodextrins in topical formulations: Practical aspectsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- 4‐Hydroxynonenal: A membrane lipid oxidation product of medicinal interestMedicinal Research Reviews, 2007
- Multifunctional nanocarriers☆Advanced Drug Delivery Reviews, 2006
- Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassayEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004